SMSPHARMA — SMS Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for SMS Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,632	5,199	5,221	7,093	7,827
Cost of Revenue
Gross Profit	1,931	2,039	1,423	2,286	2,593
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	4,643	4,377	4,996	6,242	6,781
Operating Profit	988	822	225	851	1,047
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	911	685	53.5	661	923
Provision for Income Taxes
Net Income After Taxes	610	679	38.8	492	674
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	625	622	-70.6	498	691
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	625	622	-70.6	498	691
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.39	7.35	-0.828	5.88	8.16
Dividends per Share